The Oxford/AstraZeneca, what you need to know
www.who.int/news-room/feature...
The vaccine is safe and effective for all individuals aged 18 and above.
www.bhf.org.uk/informationsup...
Is the AstraZeneca vaccine still being used in the UK?
No, the UK government is not ordering future supplies of the AstraZeneca Covid-19 vaccine.
Evidence shows that mRNA vaccines, Pfizer and Moderna, are more effective at boosting protection from Covid-19,
so these vaccines are being recommended for the autumn booster programme.
Yellow cards
www.gov.uk/government/publica...
COVID-19 Vaccine AstraZeneca
yellowcard.mhra.gov.uk/idaps/...
Essential context
yellowcard.mhra.gov.uk/idaps/...
The Medicines and Healthcare products Regulatory Agency (MHRA)
Yellow card scheme, Don’t wait for someone else to report it
www.gov.uk/drug-safety-update...
Only 10% of serious reactions reported
Only 2 and 4% of non-serious reactions are reported via yellow cards.
www.ons.gov.uk/peoplepopulati...
Deaths by vaccination status
mRNA Vaccine, serious adverse events of special
pubmed.ncbi.nlm.nih.gov/36055...
3.4. Harm-benefit considerations
In the Moderna trial
One in 662
In the Pfizer trial
One in 990
Combined
One in 800
(over placebo baselines)
Latest risk figures from UK Health Security Agency (UKHSA) presentation to the Joint Committee on Vaccination and Immunisation (JCVI)
assets.publishing.service.gov...
Table 3: NNV for prevention of hospitalisation (and severe hospitalisation) for different programmes
20 - 29 Years, Autumn booster
No risk group, 169,200 (706,500)
In a risk group, 7,500 (59,500)
50 - 59 Years, Autumn booster
No risk group, 43,600 (256,400)
In a risk group, 3,100 (18,600)
ONS, death data, W/E 27th January
www.ons.gov.uk/peoplepopulati...
Deaths registered in the UK was 15,953
2.1% above the five-year average (321 excess deaths)
Some profits
www.reuters.com/business/heal...
Western drugmakers are estimated to have brought in about $100 billion in revenue in 2022.